EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Comprehensive Insights into the Development of Antitoxoplasmosis Drugs: Current Advances, Obstacles, and Future Perspectives

Siyang Liu, Minghao Cai, Zhendi Liu, Weixin Gao, Junjie Li, Yuxueqing Li, Xiayire Abudouxukuer, Jili Zhang iD

Journal of Medicinal Chemistry · 12.12.2024 · 67 (23) · 20740-20764

DOI: 10.1021/acs.jmedchem.4c01733 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 26.11.2024. Verfasst von Siyang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Health Science Center, Ningbo University, No. 818 Fenghua Road, Jiangbei District, Ningbo 513211, China. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Toxoplasma, Toxoplasmosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 180 Literaturangaben. Gefördert von: National Youth Science Foundation, Ningbo University, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current therapies for toxoplasmosis rely on a few drugs, most of which have severe side effects, and seeking ideal therapies for different types of toxoplasmosis is a long-term and challenging mission. Research and development (R&D) of novel drugs against Toxoplasma gondii (T. gondii) has focused on two main directions, the structural modification of lead compounds and natural products. Here we summarize the recent advances in the development of anti-T. gondii drugs from these two perspectives and provide comprehensive insights, reflecting on the advantages and selected molecules in each field. This review also focuses on the current obstacles to the development of novel anti-T. gondii agents, proposes comprehensive solutions, and facilitates future development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiprotozoal AgentsToxoplasmaToxoplasmosisAnimalsHumansBiological ProductsDrug DevelopmentBenzaldehydes

Substanzen

Antiprotozoal AgentsBiological Products2-vanillinBenzaldehydes

Autor:innen und Institutionen

  • Health Science Center, Ningbo University, No. 818 Fenghua Road, Jiangbei District, Ningbo 513211, China.

ORCID-Profile: Jili Zhang

Förderung

  • National Youth Science Foundation
  • Ningbo University
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Liu, S., Cai, M., Liu, Z., Gao, W., Li, J., Li, Y., Abudouxukuer, X., & Zhang, J. (2024). Comprehensive Insights into the Development of Antitoxoplasmosis Drugs: Current Advances, Obstacles, and Future Perspectives. Journal of Medicinal Chemistry, 67(23), 20740-20764. https://doi.org/10.1021/acs.jmedchem.4c01733

Vancouver

Liu S, Cai M, Liu Z, Gao W, Li J, Li Y, et al. Comprehensive Insights into the Development of Antitoxoplasmosis Drugs: Current Advances, Obstacles, and Future Perspectives. Journal of Medicinal Chemistry. 2024;67(23):20740-20764. doi:10.1021/acs.jmedchem.4c01733

BibTeX
@article{Liu2024,
  author = {Liu, Siyang and Cai, Minghao and Liu, Zhendi and Gao, Weixin and Li, Junjie and Li, Yuxueqing and Abudouxukuer, Xiayire and Zhang, Jili},
  title = {Comprehensive Insights into the Development of Antitoxoplasmosis Drugs: Current Advances, Obstacles, and Future Perspectives},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {23},
  pages = {20740--20764},
  doi = {10.1021/acs.jmedchem.4c01733}
}
Kostenlos starten →